MetaVia Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Research and development | $6.8M | $21.6M | $9.2M | $2.8M | $6.5M |
| Operating expenses | $13.7M | $28.8M | — | — | — |
| Operating income | -$13.7M | -$28.8M | -$15.9M | -$19.6M | -$15.3M |
| Pretax income | -$13.0M | -$27.6M | -$12.5M | -$14.0M | -$15.3M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$13.0M | -$27.6M | -$12.5M | -$14.0M | -$15.3M |
| Balance Sheet | |||||
| Cash and equivalents | $10.3M | $16.0M | $22.4M | $33.4M | $16.4M |
| Current assets | $10.9M | $16.1M | $22.5M | $33.5M | $16.6M |
| Total assets | $11.1M | $16.3M | $22.8M | $33.5M | $16.8M |
| Current liabilities | $5.6M | $8.3M | $6.0M | $11.8M | $2.2M |
| Total liabilities | $5.8M | $8.3M | $6.1M | $11.8M | $2.2M |
| Stockholders' equity | $5.3M | $7.9M | $16.7M | $21.8M | $14.6M |
| Cash Flow Statement | |||||
| Cash from operations | -$15.7M | -$24.7M | -$10.8M | -$11.7M | -$15.1M |
| Depreciation and amortization | $19,000 | $20,000 | $6,000 | $20,000 | $48,000 |
| Stock-based compensation | $411,000 | $538,000 | $222,000 | $854,000 | $662,000 |
| Capital expenditure | $2,000 | $8,000 | $50,000 | — | $3,000 |
| Free cash flow | -$15.7M | -$24.7M | -$10.8M | — | -$15.1M |
Shares outstanding 5.2M · Free float 72.5%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.